Pier Capital’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-64,274
| Closed | -$5.97M | – | 119 |
|
|
2021
Q1 | $5.97M | Sell |
64,274
-45,512
| -41% | -$4.23M | 0.57% | 89 |
|
|
2020
Q4 | $9.84M | Buy |
109,786
+30,486
| +38% | +$2.73M | 1.04% | 50 |
|
|
2020
Q3 | $8.19M | Buy |
79,300
+27,712
| +54% | +$2.86M | 1.2% | 17 |
|
|
2020
Q2 | $4.08M | Sell |
51,588
-42,015
| -45% | -$3.32M | 0.65% | 88 |
|
|
2020
Q1 | $5.42M | Sell |
93,603
-8,376
| -8% | -$485K | 1.2% | 35 |
|
|
2019
Q4 | $5.5M | Sell |
101,979
-28,594
| -22% | -$1.54M | 0.9% | 63 |
|
|
2019
Q3 | $6.83M | Sell |
130,573
-17,906
| -12% | -$936K | 1.16% | 45 |
|
|
2019
Q2 | $7.17M | Buy |
148,479
+38,033
| +34% | +$1.84M | 1.11% | 47 |
|
|
2019
Q1 | $5.58M | Buy |
110,446
+57,254
| +108% | +$2.89M | 0.87% | 72 |
|
|
2018
Q4 | $3.15M | Sell |
53,192
-79,848
| -60% | -$4.73M | 0.63% | 86 |
|
|
2018
Q3 | $8.76M | Buy |
+133,040
| New | +$8.76M | 1.11% | 34 |
|